BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 2859301)

  • 1. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine blocks somatostatin secretion without altering the course of insulin or glucagon release. A new model for the study of islet function.
    Sorenson RL; Grouse LH; Elde RP
    Diabetes; 1983 Apr; 32(4):377-9. PubMed ID: 6131850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine-induced reduction in tissue somatostatin immunoreactivity is associated with alterations in somatostatin mRNA.
    Papachristou DN; Liu JL; Patel YC
    Regul Pept; 1994 Jan; 49(3):237-47. PubMed ID: 7908140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine exerts multiple effects on the endocrine cells of the rat pancreas.
    Ostenson CG; Efendić S
    Biochim Biophys Acta; 1985 Aug; 846(2):242-7. PubMed ID: 2862920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic suppression of pancreatic somatostatin secretion.
    Itoh M; Furman BL; Gerich JE
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):56-61. PubMed ID: 6126981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide directly suppresses arginine-induced glucagon secretion.
    Takahashi K; Yamatani K; Hara M; Sasaki H
    Diabetes Res Clin Pract; 1994 Jul; 24(3):143-51. PubMed ID: 7988345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.
    Gerich JE; Charles MA; Grodsky GM
    J Clin Invest; 1974 Oct; 54(4):833-41. PubMed ID: 4430717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro paracrine regulation of islet B-cell function by A and D cells.
    Fujimoto WY; Kawazu S; Ikeuchi M; Kanazawa Y
    Life Sci; 1983 Apr; 32(16):1873-8. PubMed ID: 6132317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perfused rat pancreas].
    Blech W; Bierwolf B; Weiss I; Ziegler M
    Biomed Biochim Acta; 1986; 45(4):507-22. PubMed ID: 3085662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of histamine, of histidine and of anti-histaminic agents on the release of glucagon and insulin from the rat pancreas.
    Pontiroli AE; Micossi P; Foà PP
    Horm Metab Res; 1979 Feb; 11(2):100-3. PubMed ID: 374215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
    Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
    Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas.
    Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
    Endocrinology; 1983 Dec; 113(6):1972-9. PubMed ID: 6139273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell function.
    Itoh M; Mandarino L; Gerich JE
    Diabetes; 1980 Sep; 29(9):693-6. PubMed ID: 6160072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas.
    Pontiroli AE; Micossi P; Foá PP
    Horm Metab Res; 1978 May; 10(3):200-3. PubMed ID: 352887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in the depleting effect of cysteamine on pancreatic somatostatin.
    Hashimoto N; Kanatsuka A; Makino H; Sakurada M; Yoshida S
    Horm Metab Res; 1987 Jan; 19(1):11-4. PubMed ID: 2881872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep.
    Sperling MA; Christensen RA; Ganguli S; Anand R
    Pediatr Res; 1980 Mar; 14(3):203-8. PubMed ID: 6992082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.